<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30259332</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>27</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1880-4233</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>26</Day>                    </PubDate>                </JournalIssue>                <Title>Breast cancer (Tokyo, Japan)</Title>                <ISOAbbreviation>Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Does breast cancer growth rate really depend on tumor subtype? Measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12282-018-0914-0</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Breast cancer growth is generally expected to differ between tumor subtypes. We aimed to evaluate tumor doubling time (DT) using ultrasonography and verify whether each tumor subtype has a unique DT.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study included 265 patients with invasive breast cancer who received serial ultrasonography between diagnosis and surgery. Tumor diameters were measured in three directions and DTs were calculated according to an exponential growth model using the volume change during serial ultrasonography. We investigated the relationships between DT, tumor subtype, and histopathological factors.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Volumes did not change in 95 (36%) of 265 tumors and increased in 170 (64%) tumors during serial ultrasonography (mean interval, 56.9 days). The mean volume increases of all tumors and volume-increased tumors were 22.1% and 34.5%, respectively. Triple-negative tumors had greater volume increases (40% vs. 20%, p = 0.001) and shorter DT (124 vs. 185 days, p = 0.027) than estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)- tumors. Volume-increased tumors had higher Ki-67 indices than those of volume-stable tumors in ER+/HER2- (p = 0.002) and ER+/HER2+ tumors (p = 0.011) and higher histological grades in all tumors except triple-negative tumors (p &lt; 0.001). Triple-negative tumors with DTs &lt; 90 days (short-DT) showed higher Ki-67 indices than those with DTs &gt; 90 days (long-DT) (p = 0.008). In ER+/HER2- tumors, histological grades were higher for short-DT than for long-DT tumors (p = 0.022).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Differences in tumor DT depending on breast cancer subtype, Ki-67 index, and histological grade were confirmed using serial ultrasonography even during preoperative short interval.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Nakashima</LastName>                    <ForeName>Kazuaki</ForeName>                    <Initials>K</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1023-0454</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Breast Imaging and Intervention, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan. kaz.nakashima@scchr.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Uematsu</LastName>                    <ForeName>Takayoshi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Imaging and Intervention, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takahashi</LastName>                    <ForeName>Kaoru</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nishimura</LastName>                    <ForeName>Seiichirou</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tadokoro</LastName>                    <ForeName>Yukiko</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hayashi</LastName>                    <ForeName>Tomomi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sugino</LastName>                    <ForeName>Takashi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>26</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Japan</Country>            <MedlineTA>Breast Cancer</MedlineTA>            <NlmUniqueID>100888201</NlmUniqueID>            <ISSNLinking>1340-6868</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Doubling time</Keyword>            <Keyword MajorTopicYN="N">Molecular subtype</Keyword>            <Keyword MajorTopicYN="N">Tumor growth rate</Keyword>            <Keyword MajorTopicYN="N">Ultrasonography</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30259332</ArticleId>            <ArticleId IdType="doi">10.1007/s12282-018-0914-0</ArticleId>            <ArticleId IdType="pii">10.1007/s12282-018-0914-0</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>